The China Securities Regulatory Commission's M&A and Restructuring Review Committee for Listed Companies (held the 26th M&A and Restructuring Commission working meeting in 2022 to review the company's issuance of shares and payment of cash to purchase assets and raise supporting funds and related transactions. According to the review results of the meeting, the company's restructuring matters were unconditionally approved. According to relevant regulations, after the company applies to the Shanghai Stock Exchange, trading of the company's shares will resume from the opening of the market on December 27, 2022.